Literature DB >> 25106522

Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.

Gilberto Vargas-Alarcón1, Julián Ramírez-Bello, Aurora de la Peña, Beatriz Calderón-Cruz, Marco Antonio Peña-Duque, Marco Antonio Martínez-Ríos, Silvestre Ramírez-Fuentes, Oscar Pérez-Méndez, José Manuel Fragoso.   

Abstract

The aim of the present study was to establish the gene frequency of six polymorphisms of the ABCB1, CYP3A5, CYP2C19, and P2RY12 genes in a population resident of Mexico City. The proteins encoded by these genes have been associated with the absorption, and biotransformation of clopidogrel. The ABCB1 T3435C, CYP3A5 V3 A6986G, P2RY12 G52T, P2RY12 C34T, CYP2C19 V2 and V3 (positions G681A and G636A, respectively), polymorphisms were analyzed by 5' exonuclease TaqMan genotyping assays in a group of 269 healthy unrelated Mexican Mestizo individuals. The CYP2C19 V3 G636A polymorphism was not detected in the Mexican Mestizos population. However, the studied population presented significant differences (P < 0.05) in the distribution of the T3435C, A6986G, G681A, G52T and C34T polymorphisms when compared to reported frequencies of Amerindian of South America, Caucasian, Asian, and African populations. In summary, the distribution of the ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms distinguishes to the Mexican Mestizos population from other ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25106522     DOI: 10.1007/s11033-014-3590-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  36 in total

1.  CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention.

Authors:  George Kassimis; Periklis Davlouros; Ioanna Xanthopoulou; Eleana F Stavrou; Aglaia Athanassiadou; Dimitrios Alexopoulos
Journal:  Thromb Res       Date:  2011-08-09       Impact factor: 3.944

2.  Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.

Authors:  Jung-Won Suh; Bon-Kwon Koo; Shu-Ying Zhang; Kyung-Woo Park; Joo-Youn Cho; In-Jin Jang; Dong-Soon Lee; Dae-Won Sohn; Myoung-Mook Lee; Hyo-Soo Kim
Journal:  CMAJ       Date:  2006-06-06       Impact factor: 8.262

3.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

4.  A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.

Authors:  Sarah C Sim; Carl Risinger; Marja-Liisa Dahl; Eleni Aklillu; Magnus Christensen; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal:  Clin Pharmacol Ther       Date:  2006-01       Impact factor: 6.875

5.  Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: an updated meta-analysis.

Authors:  Yan Ping Liu; Pan Pan Hao; Ming Xiang Zhang; Cheng Zhang; Fei Gao; Yun Zhang; Yu Guo Chen
Journal:  Thromb Res       Date:  2011-07-27       Impact factor: 3.944

6.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

7.  Clopidogrel: a pharmacogenomic perspective on its use in coronary artery disease.

Authors:  Chris Terpening
Journal:  Clin Med Insights Cardiol       Date:  2010-12-01

8.  Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.

Authors:  Pierre Fontana; Annabelle Dupont; Sophie Gandrille; Christilla Bachelot-Loza; Jean-Luc Reny; Martine Aiach; Pascale Gaussem
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

9.  Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.

Authors:  Joel Salazar-Flores; Luis A Torres-Reyes; Gabriela Martínez-Cortés; Rodrigo Rubi-Castellanos; Martha Sosa-Macías; José F Muñoz-Valle; César González-González; Angélica Ramírez; Raquel Román; José L Méndez; Andrés Barrera; Alfredo Torres; Rafael Medina; Héctor Rangel-Villalobos
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-22

10.  Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.

Authors:  Dietmar Trenk; Willibald Hochholzer; Martin F Fromm; Ligia-Emilia Chialda; Andreas Pahl; Christian M Valina; Christian Stratz; Peter Schmiebusch; Hans-Peter Bestehorn; Heinz Joachim Büttner; Franz-Josef Neumann
Journal:  J Am Coll Cardiol       Date:  2008-05-20       Impact factor: 24.094

View more
  10 in total

Review 1.  Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.

Authors:  I Fricke-Galindo; C Céspedes-Garro; F Rodrigues-Soares; M E G Naranjo; Á Delgado; F de Andrés; M López-López; E Peñas-Lledó; A LLerena
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

2.  Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.

Authors:  Yuesong Pan; Weiqi Chen; Yilong Wang; Hao Li; S Claiborne Johnston; Tabassome Simon; Xingquan Zhao; Liping Liu; David Wang; Xia Meng; Yongjun Wang
Journal:  JAMA Neurol       Date:  2019-05-01       Impact factor: 18.302

3.  Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.

Authors:  Alma Faviola Favela-Mendoza; Héctor Rangel-Villalobos; Ingrid Fricke-Galindo; Alberto Ortega-Vázquez; Gabriela Martínez-Cortés; Marisol López-López
Journal:  Mol Biol Rep       Date:  2018-10-13       Impact factor: 2.316

4.  Lack of Association of Generic Brittle Status with Genetics and Physiologic Measures in Patients with Epilepsy.

Authors:  Sharmila Das; Dong Guo; Xiaohui Jiang; Wenlei Jiang; Yan Shu; Tricia Y Ting; James E Polli
Journal:  Pharm Res       Date:  2020-02-26       Impact factor: 4.200

5.  CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.

Authors:  A Ortega-Vázquez; P Dorado; I Fricke-Galindo; H Jung-Cook; N Monroy-Jaramillo; I E Martínez-Juárez; I Familiar-López; E Peñas-Lledó; A LLerena; M López-López
Journal:  Pharmacogenomics J       Date:  2015-06-30       Impact factor: 3.550

6.  Omental adipose tissue gene expression, gene variants, branched-chain amino acids, and their relationship with metabolic syndrome and insulin resistance in humans.

Authors:  Aurora E Serralde-Zúñiga; Martha Guevara-Cruz; Armando R Tovar; Miguel F Herrera-Hernández; Lilia G Noriega; Omar Granados; Nimbe Torres
Journal:  Genes Nutr       Date:  2014-09-27       Impact factor: 5.523

7.  Platelet membrane receptor P2Y12 H1/H2 polymorphism is highly associated with cerebral infarction: a case-control study.

Authors:  Shu-Jun Lu; Xiao-Sheng Zhou; Qi Zheng; Hong-Liang Chen; Yan-Lei Geng
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-30       Impact factor: 2.570

8.  Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico.

Authors:  Vanessa Gonzalez-Covarrubias; Marlet Morales-Franco; Omar F Cruz-Correa; Angélica Martínez-Hernández; Humberto García-Ortíz; Francisco Barajas-Olmos; Alma Delia Genis-Mendoza; José Jaime Martínez-Magaña; Humberto Nicolini; Lorena Orozco; Xavier Soberón
Journal:  Front Pharmacol       Date:  2019-10-10       Impact factor: 5.810

9.  Influence of Genetic Admixture Components on CYP3A5*3 Allele-Associated Hypertension in Amerindian Populations From Northwest Mexico.

Authors:  Carlos Galaviz-Hernández; Blanca P Lazalde-Ramos; Ismael Lares-Assef; Alejo Macías-Salas; Margarita A Ortega-Chavez; Héctor Rangel-Villalobos; Martha Sosa-Macías
Journal:  Front Pharmacol       Date:  2020-05-11       Impact factor: 5.810

10.  Impact of genetic variants on major bleeding after percutaneous coronary intervention based on a prospective multicenter registry.

Authors:  Jung-Joon Cha; Hyung Joon Joo; Jae Hyoung Park; Soon Jun Hong; Tae Hoon Ahn; Byeong-Keuk Kim; WonYong Shin; Sung Gyun Ahn; JungHan Yoon; Yong Hoon Kim; Yun-Hyeong Cho; Woong Chol Kang; Weon Kim; Young-Hyo Lim; HyeonCheol Gwon; WoongGil Choi; Do-Sun Lim
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.